Abstract:BACKGROUND Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are rare tumors, often diagnosed in an advanced stage when curative treatment is impossible and grueling symptoms related to vasoactive substance release by tumor cells affect patients' quality of life. Cardiovascular complications of GEP-NENs, primarily tricuspid and pulmonary valve disease, and right-sided heart failure, are the leading cause of death, even compared to metastatic disease. CASE SUMMARY We present a case of a 35-year-old patient with progressive dyspnea, back pain, polyneuropathic leg pain, and nocturnal diarrhea lasting for a decade before the diagnosis of neuroendocrine carcinoma of unknown primary with extensive liver metastases. During the initial presentation, serum biomarkers were not evaluated, and the patient received five cycles of doxorubicin, which he did not tolerate well, so he refused further therapy and was lost to follow-up. After 10 years, he presented to the emergency room with signs and symptoms of right-sided heart failure. Panneuroendocrine markers, serum chromogranin A, and urinary 5-hydroxyindoleacetic acid were extremely elevated (900 ng/mL and 2178 μmol/L), and transabdominal ultrasound confirmed hepatic metastases. Computed tomography (CT) showed liver metastases up to 6 cm in diameter and metastases in mesenteric lymph nodes and pelvis. Furthermore, an Octreoscan showed lesions in the heart, thoracic spine, duodenum, and ascendent colon. A standard transthoracic echocardiogram confirmed findings of carcinoid heart disease. The patient was not a candidate for valve replacement. He started octreotide acetate treatment, and the dose escalated to 80 mg IM monthly. Although biochemical response and symptomatic improvement were noted, the patient died. CONCLUSION Carcinoid heart disease occurs with carcinoid syndrome related to advanced neuroendocrine tumors, usually with liver metastases, which manifests as right-sided heart valve dysfunction leading to right-sided heart failure. Carcinoid heart disease and tumor burden are major prognostic factors of poor survival. Therefore, they must be actively sought by available biochemical markers and imaging techniques. Moreover, imaging techniques aiding tumor detection and staging, somatostatin receptor positron emission tomography/CT, and CT or magnetic resonance imaging, should be performed at the time of diagnosis and in 3- to 6-mo intervals to determine tumor growth rate and assess the possibility of locoregional therapy and/or palliative surgery. Valve replacement at the onset of symptoms or right ventricular dysfunction may be considered, while any delay can worsen right-sided ventricular failure.

Neuroendocrine carcinoma presenting as cardiac tamponade and dramatic response to steroids

Adrenal cortical carcinoma with tumor thrombus extension into the right atrium: A case report.

Case report: A challenging case of severe Cushing's syndrome in the course of metastatic thymic neuroendocrine carcinoma with a synchronous adrenal tumor

An aggressive Cushing's syndrome originating from a rare thymic neuroendocrine tumor, controlled successfully with fluconazole and octreotide therapy before surgery

Primary pericardial angiosarcoma with pleural metastasis: an unusual clinical presentation

Acute Small Bowel Obstruction: a Rare Initial Presentation for the Metastasis of the Large-Cell Carcinoma of the Lung.

Neuroendocrine carcinoma arising in a mediastinal teratoma with pulmonary metastasis: a case report and the chemotherapy response

Primary pulmonary chondrosarcoma and a fast-growing mass that accidentally mimicked teratoma.

Thymic carcinoid with multiple bone metastases: A case report

Ectopic ACTH Syndrome Caused by Thymic Neuroendocrine Tumor: a Case Report and Literature Review.

Carcinoid Heart Disease and a Complicated Course of Progressive Gastroenteropancreatic Neuroendocrine Neoplasia: A Case Report

Managing end-stage carcinoid heart disease: A case report and literature review

Cardiac Metastases in Patients with Neuroendocrine Tumours: Clinical Features, Therapy Outcomes, and Prognostic Implications

When tissue is not the only issue: Poorly differentiated lung squamous-cell carcinoma with adrenal, costochondral, and cardiac metastases - case report

[A case of pericarditis carcinomatosa showing good response following local transfer of lymphokine-activated killer (LAK) cells]

Pancreatic Metastasis Resulting from Thymic Neuroendocrine Carcinoma: A Case Report.

Atypical location of primary cardiac lymphoma in the left heart with atypical clinical presentation: A case report and literature review

Lung Adenocarcinoma Presenting as Early Cardiac Tamponade: A Case Report

A unique case of ectopic Cushing's syndrome from a thymic neuroendocrine carcinoma

A Rare Case of Pulmonary Neuroendocrine Carcinoma in Transfusion-dependent Thalassemia Patient: Clinical Presentation, Management, and Implications

Massive myocardial infiltration by primary anaplastic T-cell lymphoma: a case report